Search results
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
CNN.com· 3 days agoThe committee voted on the question, “For the 2024-2025 Formula of COVID-19 vaccines in the U.S.,...
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Benzinga via AOL· 2 days agoThe submission is based on FDA guidance, which advised that COVID-19 vaccines should be updated to a...
New COVID-19 vaccine for fall should target JN.1 lineage, not variant, FDA panel
USA TODAY via Yahoo News· 3 days agoOfficials noted that COVID-19 is rapidly evolving. The goal of the group was to capture the virus’...
COVID shots for JN.1 variant neutralize newer strains, vaccine makers say
WSAU Wausau· 4 days ago(Reuters) - COVID-19 vaccine makers said data from animals studies showed their 2024-25 shots...
Novavax says it will have an updated Covid vaccine - Washington Business Journal
The Business Journals· 3 days agoGaithersburg’s Novavax Inc. (NASDAQ: NVAX) says it will have an updated Covid-19 vaccine ready in...
COVID shots should target JN.1 variant in fall 2024 campaign, US FDA says
Stars and Stripes· 1 day agoThe U.S. health regulator on Friday advised COVID-19 vaccine manufacturers that new shots for the...
COVID shots should target variants with JN.1 lineage in 2024-25 campaign, US FDA advisers say By...
Investing.com· 4 days agoCOVID shots should target variants with JN.1 lineage in 2024-25 campaign, US FDA advisers say
Novavax's stock surges almost 300% in the past month
Yahoo Finance· 2 days agoThe Food and Drug Administration (FDA) today finally set a deadline to review the company's COVID-19 vaccine for full approval ...
FDA Panel to Consider Updating COVID-19 Jabs for New Virus Strains
Zacks via Yahoo Finance· 5 days agoAn FDA panel meeting is scheduled on Jun 5 to consider if COVID-19 vaccines should be updated to...
There's another COVID variant you should know about: KP.3 now makes up 25% of COVID cases
USA TODAY via Yahoo News· 7 hours agoCOVID fall vaccine will target JN.1 The dominant emergence of the KP...experts from vaccine manufacturers Pfizer, Moderna and